Stockscreener 앱 받기
13.52
4.00%
0.52
시간 외 거래:
13.57
0.05
+0.37%
전일 마감가:
$13.00
열려 있는:
$13.04
하루 거래량:
1.42M
Relative Volume:
1.19
시가총액:
$782.92M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+13.14%
1개월 성능:
+0.07%
6개월 성능:
-43.00%
1년 성능:
+0.00%
1일 변동 폭
$12.86
$13.82
1주일 범위
$11.92
$13.82
52주 변동 폭
$10.28
$26.91
Omada Health Inc Stock (OMDA) Company Profile
명칭
Omada Health Inc
전화
888-987-8337
주소
611 GATEWAY BLVD., SOUTH SAN FRANCISCO
Compare OMDA vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMDA
Omada Health Inc
|
13.52 | 752.80M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 개시 | Wells Fargo | Equal Weight |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-09-05 | 개시 | Robert W. Baird | Neutral |
| 2025-07-01 | 개시 | Barclays | Overweight |
| 2025-07-01 | 개시 | Canaccord Genuity | Buy |
| 2025-07-01 | 개시 | Evercore ISI | Outperform |
| 2025-07-01 | 개시 | Goldman | Buy |
| 2025-07-01 | 개시 | JP Morgan | Overweight |
| 2025-07-01 | 개시 | Morgan Stanley | Overweight |
| 2025-07-01 | 개시 | Needham | Buy |
모두보기
Omada Health Inc 주식(OMDA)의 최신 뉴스
Assessing Omada Health: Insights From 4 Financial Analysts - Benzinga
Barclays Lowers Price Target for OMDA, Maintains Overweight Rati - GuruFocus
Omada Health (NASDAQ:OMDA) Given New $17.00 Price Target at Barclays - MarketBeat
Digital Therapeutics Market to Reach US$ 39.52 Billion by 2033 | - openPR.com
7MM Digital Therapeutics for Diabetes Market Set for Strong - openPR.com
BIT Capital GmbH Makes New $13.64 Million Investment in Omada Health, Inc. $OMDA - MarketBeat
Virtual coaching tackles high cholesterol, a key heart risk driver - Stock Titan
Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk - The Manila Times
OMDA Should I Buy - Intellectia AI
Omada Health, Inc. (NASDAQ:OMDA) Short Interest Update - MarketBeat
Omada Health (NASDAQ:OMDA) Shares Gap UpHere's Why - MarketBeat
Omada Health, Inc. (NASDAQ:OMDA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Omada Health, Inc. (NASDAQ:OMDA) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - 富途牛牛
Omada Health (NASDAQ:OMDA) Hits New 12-Month LowHere's Why - MarketBeat
Omada Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 5, 2026 - The Manila Times
Omada Health, Inc. (NASDAQ:OMDA) Short Interest Down 54.4% in January - MarketBeat
Voyager Stock Up 12% Post-IPO as One Fund Commits Nearly 30% of Assets - The Motley Fool
Emerald Mutual Fund Advisers Trust Sells 99,302 Shares of Omada Health, Inc. $OMDA - MarketBeat
Omada Health (NASDAQ:OMDA) Stock Price Up 4.5%Should You Buy? - MarketBeat
Omada Health Inc (OMDA) Trading 6.32% Higher on Jan 23 - GuruFocus
OMDA: Needham Reiterates Buy Rating with $28 Price Target | OMDA Stock News - GuruFocus
Omada Health (NASDAQ:OMDA) Earns "Buy" Rating from Needham & Company LLC - MarketBeat
Omada Health: Strong 2025 Finish, GLP-1 Tailwinds, and Attractive 2026 Valuation Upside Support Reiterated Buy Rating - TipRanks
Omada Health expects Q4 revenue to be between $72M and $74M - MSN
Omada Health (NASDAQ:OMDA) Is In A Strong Position To Grow Its Business - Yahoo Finance
Omada Health, Inc. (NASDAQ:OMDA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Analysts Offer Insights on Healthcare Companies: Aveanna Healthcare Holdings (AVAH), Omada Health, Inc. (OMDA) and United Therapeutics (UTHR) - The Globe and Mail
Is Omada Health, Inc. (NASDAQ:OMDA) Trading At A 34% Discount? - simplywall.st
Omada Health CEO Makes Major Move With High-Value Stock Sale - TipRanks
Insider Selling: Omada Health (NASDAQ:OMDA) CEO Sells 230,479 Shares of Stock - MarketBeat
Omada Health (NASDAQ:OMDA) CEO Sells $650,696.20 in Stock - MarketBeat
OMDA: 52% revenue growth and GLP-1 prescribing drive Omada's expansion and margin gains - TradingView — Track All Markets
Canaccord Genuity reiterates Buy rating on Omada Health stock By Investing.com - Investing.com South Africa
Omada Health: Accelerating Membership and Revenue Growth Underpins Buy Rating and Upside Potential - TipRanks
Canaccord Genuity reiterates Buy rating on Omada Health stock - Investing.com
How Omada Health scaled patient care by fine-tuning Llama models on Amazon SageMaker AI - Amazon Web Services (AWS)
Omada Health reports 51-52% revenue growth for 2025 By Investing.com - Investing.com Canada
Omada Health Reports Preliminary, Unaudited Revenue For The Fourth Quarter And Fiscal Year 2025 - TradingView
Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025 - marketscreener.com
Omada Health (NASDAQ:OMDA) Upgraded at Wells Fargo & Company - MarketBeat
Omada Health (NASDAQ:OMDA) Shares Down 5.9%Here's What Happened - MarketBeat
Demystifying Omada Health: Insights From 7 Analyst Reviews - Benzinga
Wells Fargo Initiates Coverage on OMDA with Equal-Weight Rating - GuruFocus
Omada Health stock initiated at Equal Weight by Wells Fargo with $17 target By Investing.com - Investing.com Nigeria
Omada Health stock initiated at Equal Weight by Wells Fargo with $17 target - Investing.com South Africa
Omada Health reports higher weight loss in GLP-1 program users - Investing.com India
Omada Health rises as weight loss program shows strong results in year-long study - TradingView — Track All Markets
Top Omada Health (OMDA) Competitors 2026 - MarketBeat
Omada Health Inc (OMDA) 재무 분석
Omada Health Inc (OMDA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.25%
1.11%
자본화:
|
볼륨(24시간):